Christie Hurt, DO
Family Medicine · Aurora, MONPI 1073603403
Payments from drug & device makers
Across 33 payments — averaging $18.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$78
- Pfizer$66
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$61
- Exact Sciences$53
- AstraZeneca$52
- Abbott$48
- plus $252 from 9 others
What the payments were for
- Food & beverage$611100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 5 | $78 |
| Pfizer | 3 | $66 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $61 |
| Exact Sciences | 3 | $53 |
| AstraZeneca | 3 | $52 |
| Abbott | 2 | $48 |
| Phathom Pharmaceuticals, Inc. | 2 | $41 |
| Novo Nordisk | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Mylan Specialty L.p. | 2 | $32 |
| Merck | 2 | $30 |
| Astellas Pharma US Inc | 1 | $25 |
| Lilly USA, LLC | 1 | $20 |
| Bayer | 1 | $16 |
| Lundbeck LLC | 1 | $14 |
How this compares
$611 in reported general payments places this provider in the 55th percentile of 2,203 family medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 171 | $174,520 |
| OzempicSemaglutide | 66 | $78,060 |
| JanuviaSitagliptin Phosphate | 76 | $67,659 |
| JardianceEmpagliflozin | 71 | $66,578 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 61 | $58,090 |
| RybelsusSemaglutide | 29 | $51,355 |
| XareltoRivaroxaban | 56 | $46,416 |
| MounjaroTirzepatide | 23 | $45,106 |
| SymbicortBudesonide/Formoterol Fumarate | 98 | $25,847 |
| Spiriva HandihalerTiotropium Bromide | 30 | $21,589 |
| EntrestoSacubitril/Valsartan | 13 | $21,481 |
| TrulicityDulaglutide | 17 | $20,785 |
| CreonLipase/Protease/Amylase | 15 | $19,481 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 17 | $18,709 |
| MyrbetriqMirabegron | 22 | $17,776 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Abrysvo | $66 | $186,092211 claims |
| Novo NordiskOzempic, Rybelsus | $37 | $129,41595 claims |
| MerckJanuvia | $30 | $67,65976 claims |
| Lilly USA, LLCMounjaro, Trulicity | $20 | $65,89140 claims |
| AstraZenecaSymbicort, Breztri Aerosphere, Farxiga, Bevespi Aerosphere | $52 | $63,392142 claims |
| AbbVieCreon, Savella, Synthroid | $78 | $35,02486 claims |
| Astellas Pharma US IncMyrbetriq | $25 | $17,77622 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Aurora
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
- George CarrJefferson City$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.